Pharmaceutical Technology Europe
Biotechnological developments have led to an increased number of recombinant proteins or antibodies in drug development that offer high potential in various diseases, such as cancer, growth disturbances and diabetes.
Eric Ezan
Advertisement
Articles by Eric Ezan
Advertisement
Latest Updated Articles
Bioanalysis of recombinant proteins by mass spectrometrySeptember 1st 2008
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
France Remains One of Europe’s Leading Biotech Funding Hubs
2
CPHI Pharma Award Winner: Drug Delivery, Devices, & Packaging
3
Investing in Protecting Pharma Products
4
Signs Point to FDA Shelving Priority Voucher Pilot, Stalling Fast-Track Drug Reviews
5